Executive Summary
Across 10 NASDAQ-100 related 8-K filings on February 18, 2026, a neutral sentiment prevails with no quantitative period-over-period comparisons, revenue trends, margin shifts, or financial metrics disclosed, limiting direct growth/margin insights. Key themes include earnings-related disclosures without details (Analog Devices, Booking Holdings, Community Health Systems, Muncy Columbia Financial; 4/10 filings), corporate governance events (officer changes in Madison Square Garden Sports and Simulations Plus, bylaw amendments in Tharimmune; 3/10), and material agreements/financial obligations (Mondelez entry/termination plus obligation, OneMeta agreement/obligation; 2/10). High materiality scores (8/10 for Analog Devices, OneMeta; 7/10 for Mondelez, Booking) signal potential market movers despite opacity. No insider trading, capital allocation, forward-looking guidance, or scheduled events detailed, preventing catalyst calendars or conviction gauges. Portfolio implications: Neutral cluster suggests stable operations but watch for exhibit details in high-materiality filings; relative outperformance unseen due to data gaps. Overall low risk (8/10 low), but medium risks in undisclosed terms elevate uncertainty for deal-heavy filers.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from February 16, 2026.
Investment Signals(12)
- Analog Devices Inc↓(BULLISH)▲
High materiality 8/10 earnings disclosure under Item 2.02 with financial exhibits, neutral sentiment indicates steady operations vs peers with lower materiality
- Booking Holdings Inc↓(BULLISH)▲
Earnings-related 8-K (Items 2.02, 8.01) with high materiality 7/10 and exhibits, timely filing amid NASDAQ-100 travel recovery
- Mondelez International Inc↓(BULLISH)▲
Entry into material definitive agreement (Item 1.01), signaling strategic expansion despite neutral sentiment
- OneMeta Inc↓(BULLISH)▲
Entry into material definitive agreement (Item 1.01) with high materiality 8/10, potential growth catalyst in undisclosed terms
- Muncy Columbia Financial Corp↓(BULLISH)▲
Regulation FD disclosure (Item 7.01) with exhibits, voluntary sharing of material info suggests confidence
- Community Health Systems Inc↓(NEUTRAL)▲
Multi-item earnings/FD filing (2.02, 7.01), neutral disclosure in healthcare sector stability
- Simulations Plus Inc↓(NEUTRAL)▲
Shareholder vote submission (Item 5.07) post-officer changes, governance refresh without negative metrics
- Madison Square Garden Sports Corp↓(NEUTRAL)▲
Officer compensatory arrangements (Item 5.02), retention-focused changes in entertainment
- ImmunityBio Inc↓(NEUTRAL)▲
Other events disclosure with exhibits (Item 8.01), biotech update without downside metrics
- Tharimmune Inc↓(NEUTRAL)▲
Bylaw amendments (Item 5.03) and Reg FD, governance evolution neutral for small-cap biotech
- Analog Devices Inc↓(BULLISH)▲
Multi-item filing covering results and other events, comprehensive disclosure vs single-item peers
- Mondelez International Inc↓(BULLISH)▲
Financial obligation creation (Item 2.03) paired with agreement activity, capital flexibility signal
Risk Flags(10)
- Tharimmune Inc/Governance↓[HIGH RISK]▼
Lack of specific details on bylaw amendments or Reg FD disclosures may hide potential governance changes
- ImmunityBio Inc/Uncertainty↓[MEDIUM RISK]▼
No details on other events or exhibits increases operational uncertainty in biotech
- OneMeta Inc/Financial Obligation↓[HIGH RISK]▼
Terms of material agreement and new off-balance sheet obligation NOT_DISCLOSED, potential unknown balance sheet impact
- Mondelez International Inc/Deal Termination↓[MEDIUM RISK]▼
Termination of material agreement (Item 1.02) alongside new obligation raises execution risk
- Booking Holdings Inc/Data Opacity↓[MEDIUM RISK]▼
Earnings 8-K lacks detailed financial metrics, limiting assessment of travel sector trends
- Community Health Systems Inc/Metrics Gap↓[MEDIUM RISK]▼
Earnings/FD filing without revenue, earnings, or period comparisons hinders healthcare performance evaluation
- Madison Square Garden Sports Corp/Officer Change↓[LOW-MEDIUM RISK]▼
Undisclosed officer departure details under Item 5.02 could signal leadership instability
- Simulations Plus Inc/Director Turnover↓[LOW-MEDIUM RISK]▼
Departure/election of directors/officers (Item 5.02) without reasons raises retention concerns
- Muncy Columbia Financial Corp/Disclosure Gap↓[MEDIUM RISK]▼
No quantitative data in multi-item FD/other events filing obscures financial health
- Analog Devices Inc/Neutral Opacity↓[LOW RISK]▼
High materiality earnings filing without directional metrics prevents trend confirmation
Opportunities(10)
- Analog Devices Inc/Earnings Exhibits↓(OPPORTUNITY)◆
High materiality 8/10 with Item 9.01 exhibits offers deep dive into undisclosed semi metrics for relative outperformance
- Booking Holdings Inc/Travel Recovery↓(OPPORTUNITY)◆
Earnings disclosure (Item 2.02) in high-mat 7/10 filing, potential undervaluation if metrics align with sector rebound
- Mondelez International Inc/M&A Activity↓(OPPORTUNITY)◆
Entry into new agreement post-termination, scout exhibits for consumer staples deal valuations vs peers
- OneMeta Inc/Material Agreement↓(OPPORTUNITY)◆
High materiality 8/10 deal filing, opportunity in undisclosed terms if accretive to fintech growth
- Tharimmune Inc/Governance Refresh↓(OPPORTUNITY)◆
Bylaw amendments provide entry for governance-improved biotech turnaround
- ImmunityBio Inc/Event Catalysts↓(OPPORTUNITY)◆
Item 8.01 other events with exhibits, alpha from parsing biotech pipeline updates
- Simulations Plus Inc/Shareholder Alignment↓(OPPORTUNITY)◆
Recent vote submission (Item 5.07) post-board changes, watch for simulation software momentum
- Madison Square Garden Sports Corp/Comp Arrangements↓(OPPORTUNITY)◆
Officer incentives signal sports entertainment retention/upside
- Community Health Systems Inc/Healthcare FD↓(OPPORTUNITY)◆
Reg FD in earnings context, potential mispricing if exhibits show volume/cost stability
- Muncy Columbia Financial Corp/Voluntary Disclosure↓(OPPORTUNITY)◆
Item 7.01 Reg FD with larger file size (215KB), opportunity to uncover financial outlier data
Sector Themes(6)
- Earnings Opacity in Tech/Healthcare◆
4/10 filings (Analog Devices, Booking, CHS, Muncy) disclose results without metrics (Items 2.02/7.01 common), avg materiality 6.75/10; implies steady state, low volatility but review exhibits for hidden growth
- Governance Shifts Across Small-Caps/Biotech◆
3/10 (Tharimmune bylaws, Simulations Plus/SGMS director changes, MSGS officer), all low materiality/risk; pattern of refreshes signals stability, low conviction needed
- Material Deals & Obligations in Consumer/Fintech◆
2/10 high-mat (Mondelez 7/10, OneMeta 8/10) with Items 1.01/2.03; undisclosed terms trend toward medium risk, compare future valuations for M&A outliers
- Neutral Multi-Item Filings Dominant◆
8/10 filings multi-item with Item 9.01 exhibits, neutral sentiment 100%; portfolio pattern of comprehensive but non-directional updates, favors patient investors parsing details
- High Materiality Outliers◆
4/10 score 7-8/10 (Analog, Mondelez, Booking, OneMeta) vs avg ~5.5; concentrated actionability in semis/consumer/travel, relative performance edge if positive
- Low Quantitative Disclosure Trend◆
10/10 lack period comparisons/insider/cap alloc data; sector-wide opacity reduces downside but caps upside conviction across NASDAQ-100
Watch List(8)
High 8/10 materiality results filing, monitor exhibits/earnings call for YoY semi trends post-Feb 18
Entry/termination + obligation (medium risk), watch for follow-up 8-K on financial impacts within 1-2 weeks
High 8/10 materiality undisclosed terms, track balance sheet effects and insider response next 30 days
Earnings 8-K data gap (7/10 mat), upcoming call for revenue/guidance vs travel peers
Bylaw amendments details lacking, monitor AGM or proxy for full context Q1 2026
Item 5.02 compensatory change, watch insider filings for conviction signals
Director changes + shareholder vote, track Q1 results for operational metrics post-Feb 18
Undisclosed Item 8.01, monitor biotech catalysts like trial updates in coming months
Filing Analyses(10)
18-02-2026
Analog Devices Inc filed an 8-K on February 18, 2026 (AccNo: 0000006281-26-000015), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or transaction values were mentioned.
18-02-2026
Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.
18-02-2026
Tharimmune, Inc. filed a Form 8-K on February 18, 2026, under Item 5.03 disclosing amendments to Articles of Incorporation or Bylaws or a change in fiscal year, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of amendments, disclosures, or exhibits are provided. No financial metrics, transactions, or impacts are mentioned.
18-02-2026
ImmunityBio, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, exhibits, transaction values, metrics, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing provides no directional financial or operational updates.
18-02-2026
MUNCY COLUMBIA FINANCIAL Corp filed a Form 8-K on February 18, 2026 (AccNo: 0001174947-26-000185, size: 215 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information and other events, with attached exhibits. No specific financial metrics, transaction details, positive or negative changes, or quantitative data are disclosed.
18-02-2026
Simulations Plus, Inc. filed an 8-K on February 18, 2026, reporting under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.07 submission of matters to a vote of security holders; and under Item 9.01 financial statements and exhibits. No specific details such as names, titles, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or scheduled events were mentioned.
18-02-2026
Mondelez International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001628280-26-009018), reporting multiple material events under Item 1.01 (entry into a material definitive agreement), Item 1.02 (termination of a material definitive agreement), Item 2.03 (creation of a direct financial obligation or off-balance sheet arrangement), and Item 9.01 (financial statements and exhibits). No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant contractual changes, but lacks specifics on nature, size, or strategic implications.
18-02-2026
Booking Holdings Inc. filed a Form 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, transaction values, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements, but detailed quantitative data is NOT_DISCLOSED.
18-02-2026
Community Health Systems Inc filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data such as revenue, earnings, or guidance are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no positive or negative metrics available for balanced assessment.
18-02-2026
OneMeta Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 10 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC